Trastuzumab‐containing regimens for metastatic breast cancer

BACKGROUND: Patients with breast cancer are classified as having cells that over‐express the human epidermal growth factor receptor 2 (known as HER2‐positive) or not (HER2‐negative). Typically, patients with HER2‐positive disease have a worse prognosis. Trastuzumab is a selective treatment that targ...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cochrane Database Syst Rev
Huvudupphovsmän: Balduzzi, Sara, Mantarro, Stefania, Guarneri, Valentina, Tagliabue, Ludovica, Pistotti, Vanna, Moja, Lorenzo, D'Amico, Roberto
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Ltd 2014
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464904/
https://ncbi.nlm.nih.gov/pubmed/24919460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD006242.pub2
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk